8 studies found for:    PKM
Show Display Options
Rank Status Study
1 Unknown  Phosphate Kinetic Modeling
Conditions: End Stage Renal Disease;   Hyperphosphatemia
Intervention: Other: Computer algorithm management of hyperphosphatemia
2 Active, not recruiting Phosphate Kinetic Modeling 2
Conditions: Hyperphosphatemia;   ESRD
Intervention: Other: PKM Algorithm
3 Unknown  Pyruvate Kinase Isoform M2 (PKM2) as a Possible Biomarker for Cancer
Condition: Cancer
Intervention: Other: Pyruvate kinase isoform M2
4 Terminated Study of AVE5026 at Weight-adjusted Doses in Children With a Central Venous Line
Condition: Thrombosis Prophylaxis (Risk of Thrombosis Due to Central Venous Line (CVL)
Intervention: Drug: Semuloparin sodium
5 Completed Pharmacokinetics and Safety Study With Alfuzosin in Children and Adolescents With Elevated Detrusor Leak Point Pressure of Neuropathic Etiology
Condition: Urinary Bladder Neurogenic
Intervention: Drug: alfuzosin (SL770499)
6 Completed Comparison of the Safety and Pharmacokinetics of Two SAR153191 (REGN88) Drug Products in Rheumatoid Arthritis Patients
Condition: Rheumatoid Arthritis
Intervention: Drug: SAR153191 (REGN88)
7 Completed Comparison of the Pharmacokinetics and Safety of Two SAR231893 (REGN668) Drug Products in Healthy Subjects
Condition: Healthy
Interventions: Biological: SAR231893 (REGN668) DP1;   Biological: SAR231893 (REGN668) DP2
8 Completed Pharmacokinetic Study of Single Doses of Clopidogrel, 75 mg and 300 mg, in Healthy Subjects
Condition: Healthy
Intervention: Drug: Clopidogrel

Indicates status has not been verified in more than two years